| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| H0020 |
Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) |
40,092 |
1,831 |
$754K |
| 90837 |
Psychotherapy, 53 minutes with patient |
4,428 |
1,648 |
$599K |
| S0280 |
Medical home program, comprehensive care coordination and planning, initial plan |
1,857 |
1,847 |
$541K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,298 |
1,862 |
$499K |
| H0004 |
Behavioral health counseling and therapy, per 15 minutes |
3,450 |
1,306 |
$312K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
5,605 |
1,907 |
$213K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,879 |
770 |
$134K |
| H0003 |
Alcohol and/or drug screening; laboratory analysis of specimens for presence of alcohol and/or drugs |
7,381 |
2,332 |
$133K |
| H0001 |
Alcohol and/or drug assessment |
668 |
649 |
$117K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
487 |
483 |
$95K |
| H0005 |
Alcohol and/or drug services; group counseling by a clinician |
2,765 |
1,212 |
$88K |
| H0033 |
Oral medication administration, direct observation |
5,275 |
294 |
$42K |
| 90838 |
|
519 |
207 |
$37K |
| H0048 |
Alcohol and/or other drug testing: collection and handling only, specimens other than blood |
1,223 |
660 |
$31K |
| T1012 |
Alcohol and/or substance abuse services, skills development |
508 |
327 |
$27K |
| H0006 |
Alcohol and/or drug services; case management |
691 |
359 |
$15K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
259 |
147 |
$13K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
99 |
71 |
$12K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
56 |
39 |
$11K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
97 |
58 |
$9K |
| 99215 |
Prolong outpt/office vis |
62 |
17 |
$7K |
| G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) |
58 |
13 |
$5K |
| 90832 |
Psychotherapy, 30 minutes with patient |
32 |
31 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
29 |
25 |
$786.64 |